Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook

Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook
MSN Money - 1 hour ago
MORRISTOWN, NJ, July 29 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. WPI, a leader in generic and specialty branded pharmaceuticals, today reported net income of $53.0 million, or $0.46 ...